vs
Lemonade, Inc.（LMND）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Lemonade, Inc.的季度营收约是REPLIGEN CORP的1.2倍（$228.1M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -9.5%，领先16.2%），Lemonade, Inc.同比增速更快（53.3% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-25.9M），过去两年Lemonade, Inc.的营收复合增速更高（38.4% vs 14.4%）
Lemonade, Inc.是一家总部位于美国纽约的保险公司，在美国市场提供租客险、房屋险、车险、宠物险及定期寿险，在德国、荷兰推出财产及责任保险，法国市场提供租客险，当前拥有约290万用户，采用人工智能及聊天机器人替代人工处理理赔申请。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LMND vs RGEN — 直观对比
营收规模更大
LMND
是对方的1.2倍
$197.9M
营收增速更快
LMND
高出39.6%
13.6%
净利率更高
RGEN
高出16.2%
-9.5%
自由现金流更多
RGEN
多$43.5M
$-25.9M
两年增速更快
LMND
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $228.1M | $197.9M |
| 净利润 | $-21.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -9.0% | 9.0% |
| 净利率 | -9.5% | 6.7% |
| 营收同比 | 53.3% | 13.6% |
| 净利润同比 | 27.7% | 143.9% |
| 每股收益（稀释后） | $-0.27 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LMNDRGEN
| Q4 25 | $228.1M | $197.9M | ||
| Q3 25 | $194.5M | $188.8M | ||
| Q2 25 | $164.1M | $182.4M | ||
| Q1 25 | $151.2M | $169.2M | ||
| Q4 24 | $148.8M | $174.1M | ||
| Q3 24 | $136.6M | $154.9M | ||
| Q2 24 | $122.0M | $154.1M | ||
| Q1 24 | $119.1M | $151.3M |
净利润LMNDRGEN
| Q4 25 | $-21.7M | $13.3M | ||
| Q3 25 | $-37.5M | $14.9M | ||
| Q2 25 | $-43.9M | $14.9M | ||
| Q1 25 | $-62.4M | $5.8M | ||
| Q4 24 | $-30.0M | $-30.3M | ||
| Q3 24 | $-67.7M | $-654.0K | ||
| Q2 24 | $-57.2M | $3.3M | ||
| Q1 24 | $-47.3M | $2.1M |
毛利率LMNDRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率LMNDRGEN
| Q4 25 | -9.0% | 9.0% | ||
| Q3 25 | -18.7% | 8.9% | ||
| Q2 25 | -26.0% | 7.6% | ||
| Q1 25 | -40.6% | 3.9% | ||
| Q4 24 | -25.4% | -17.7% | ||
| Q3 24 | -48.2% | -5.1% | ||
| Q2 24 | -45.2% | 1.0% | ||
| Q1 24 | -38.0% | 1.3% |
净利率LMNDRGEN
| Q4 25 | -9.5% | 6.7% | ||
| Q3 25 | -19.3% | 7.9% | ||
| Q2 25 | -26.8% | 8.2% | ||
| Q1 25 | -41.3% | 3.4% | ||
| Q4 24 | -20.2% | -17.4% | ||
| Q3 24 | -49.6% | -0.4% | ||
| Q2 24 | -46.9% | 2.2% | ||
| Q1 24 | -39.7% | 1.4% |
每股收益（稀释后）LMNDRGEN
| Q4 25 | $-0.27 | $0.24 | ||
| Q3 25 | $-0.51 | $0.26 | ||
| Q2 25 | $-0.60 | $0.26 | ||
| Q1 25 | $-0.86 | $0.10 | ||
| Q4 24 | $-0.42 | $-0.55 | ||
| Q3 24 | $-0.95 | $-0.01 | ||
| Q2 24 | $-0.81 | $0.06 | ||
| Q1 24 | $-0.67 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $533.6M | $2.1B |
| 总资产 | $1.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资LMNDRGEN
| Q4 25 | $399.1M | $767.6M | ||
| Q3 25 | $369.4M | $748.7M | ||
| Q2 25 | $398.8M | $708.9M | ||
| Q1 25 | $329.7M | $697.2M | ||
| Q4 24 | $403.5M | $757.4M | ||
| Q3 24 | $360.9M | $784.0M | ||
| Q2 24 | $387.2M | $809.1M | ||
| Q1 24 | $300.8M | $780.6M |
总债务LMNDRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LMNDRGEN
| Q4 25 | $533.6M | $2.1B | ||
| Q3 25 | $516.2M | $2.1B | ||
| Q2 25 | $527.1M | $2.1B | ||
| Q1 25 | $545.5M | $2.0B | ||
| Q4 24 | $593.4M | $2.0B | ||
| Q3 24 | $593.0M | $2.0B | ||
| Q2 24 | $635.2M | $2.0B | ||
| Q1 24 | $676.4M | $2.0B |
总资产LMNDRGEN
| Q4 25 | $1.9B | $2.9B | ||
| Q3 25 | $1.9B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $1.8B | $2.8B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $1.7B | $2.9B | ||
| Q1 24 | $1.6B | $2.8B |
负债/权益比LMNDRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-25.9M | $17.6M |
| 自由现金流率自由现金流/营收 | -11.4% | 8.9% |
| 资本支出强度资本支出/营收 | 4.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-69.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流LMNDRGEN
| Q4 25 | $-16.5M | $25.7M | ||
| Q3 25 | $4.5M | $48.1M | ||
| Q2 25 | $5.5M | $28.6M | ||
| Q1 25 | $-47.2M | $15.0M | ||
| Q4 24 | $-11.4M | $39.2M | ||
| Q3 24 | $16.3M | $49.3M | ||
| Q2 24 | $-11.7M | $42.2M | ||
| Q1 24 | $-29.8M | $44.7M |
自由现金流LMNDRGEN
| Q4 25 | $-25.9M | $17.6M | ||
| Q3 25 | $2.6M | $43.4M | ||
| Q2 25 | $3.4M | $21.5M | ||
| Q1 25 | $-49.5M | $11.4M | ||
| Q4 24 | $-20.8M | $33.6M | ||
| Q3 24 | $14.1M | $42.3M | ||
| Q2 24 | $-13.2M | $37.4M | ||
| Q1 24 | $-32.3M | $36.4M |
自由现金流率LMNDRGEN
| Q4 25 | -11.4% | 8.9% | ||
| Q3 25 | 1.3% | 23.0% | ||
| Q2 25 | 2.1% | 11.8% | ||
| Q1 25 | -32.7% | 6.8% | ||
| Q4 24 | -14.0% | 19.3% | ||
| Q3 24 | 10.3% | 27.3% | ||
| Q2 24 | -10.8% | 24.3% | ||
| Q1 24 | -27.1% | 24.0% |
资本支出强度LMNDRGEN
| Q4 25 | 4.1% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 1.3% | 3.9% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 6.3% | 3.2% | ||
| Q3 24 | 1.6% | 4.5% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 2.1% | 5.5% |
现金转化率LMNDRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
